| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1056/NEJM199201303260506 |
| P698 | PubMed publication ID | 1728735 |
| P50 | author | Lina Badimon | Q38545654 |
| Valentín Fuster Carulla | Q977751 | ||
| P2093 | author name string | Badimon JJ | |
| Chesebro JH | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | coronary artery disease | Q844935 |
| acute coronary syndrome | Q266018 | ||
| P304 | page(s) | 310-318 | |
| P577 | publication date | 1992-01-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | The pathogenesis of coronary artery disease and the acute coronary syndromes (2). | |
| P478 | volume | 326 |
| Q95409111 | Q95409111 |
| Q30576842 | 30-day in-hospital mortality after acute myocardial infarction in Tuscany (Italy): an observational study using hospital discharge data |
| Q27348866 | A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats |
| Q44612330 | A comparison of tissue prolapse with optical coherence tomography and intravascular ultrasound after drug-eluting stent implantation |
| Q34800954 | A few immobilized thrombins are sufficient for platelet spreading |
| Q37639809 | A pathological study of the epidemiology of atherosclerosis in Mexico city |
| Q37994174 | A2 adenosine receptors and vascular pathologies |
| Q77766373 | ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Ang |
| Q71724580 | ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) |
| Q77231603 | Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice |
| Q40112298 | Absolute coronary artery calcium scores are superior to MESA percentile rank in predicting obstructive coronary artery disease |
| Q62977698 | Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy |
| Q37466848 | Activation of liver X receptor attenuates lysophosphatidylcholine-induced IL-8 expression in endothelial cells via the NF-κB pathway and SUMOylation. |
| Q73364939 | Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors |
| Q41582118 | Acute and chronic psychological risk factors for coronary syndromes: moderating effects of coronary artery disease severity |
| Q30490718 | Acute coronary syndromes: diagnosis and management, part I |
| Q34155645 | Acute coronary syndromes: extending medical intervention for five days before proceeding to revascularization |
| Q33827278 | Acute coronary syndromes: pathology, diagnosis, genetics, prevention, and treatment |
| Q73138978 | Acute myocardial infarction |
| Q73720006 | Acute vigorous exercise attenuates sensitivity of platelets to nitric oxide |
| Q37864112 | Adenosine and blood platelets |
| Q37554115 | Adjunctive low molecular weight heparin during fibrinolytic therapy in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials. |
| Q77766241 | Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring. TRIM study group. Thrombin Inhibition in Myocardial Ischemia |
| Q79086329 | Aggregates of endothelial microparticles and platelets circulate in peripheral blood. Variations during stable coronary disease and acute myocardial infarction |
| Q34308216 | Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling |
| Q53897107 | An ischemia-guided approach for risk stratification in patients with acute coronary syndromes. |
| Q47133817 | Analgesic therapy improves arterial endothelial function following non-cardiovascular surgery: A randomized, placebo-controlled trial |
| Q73681249 | Angiographic Morphology Following Heparin and Aspirin Therapy in Patients with Acute Coronary Syndromes and Intracoronary Thrombus |
| Q36862820 | Angioscopy variables predictive of early angiographic outcome after excimer laser-assisted coronary angioplasty |
| Q33588514 | Antibiotics for myocardial infarction? A possible role of infection in atherogenesis and acute coronary syndromes |
| Q89177868 | Anticoagulant Therapy for Acute Coronary Syndromes |
| Q24194752 | Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication |
| Q34424085 | Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication. |
| Q37867289 | Anticoagulation in the management of ST-segment elevation myocardial infarction |
| Q30402038 | Anticoagulation in the management of non-ST-segment elevation acute coronary syndrome |
| Q50908731 | Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial. |
| Q77746918 | Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure |
| Q36835862 | Antiplatelet drugs in cardiological practice: established strategies and new developments |
| Q34111901 | Antiplatelet medications and their indications in preventing and treating coronary thrombosis |
| Q53476976 | Antiplatelet therapy and platelet function testing. Introduction. |
| Q33732646 | Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection. |
| Q35773210 | Antiplatelet treatment for coronary heart disease |
| Q73364778 | Antithrombotic Therapy during Percutaneous Coronary Intervention |
| Q74344448 | Antithrombotic therapy in acute coronary syndromes |
| Q33635831 | Antithrombotic therapy of unstable angina and non-Q-wave myocardial infarction |
| Q41341898 | Antithrombotic treatment in stable coronary syndromes: long-term intermittent urokinase therapy in end-stage coronary artery disease and refractory angina pectoris |
| Q81351174 | Aortic atherosclerosis and stroke |
| Q35782561 | Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. |
| Q38739380 | Arterial ageing: from endothelial dysfunction to vascular calcification. |
| Q28165677 | Aspirin for the prevention of cardiovascular events in the elderly |
| Q36931606 | Association between abdominal aortic plaque and coronary artery disease |
| Q51551601 | Association between periodontal disease and acute myocardial infarction. |
| Q54507517 | Association of endothelin-1 gene polymorphisms with variant angina in Korean patients. |
| Q83306166 | Association of glycoprotein IIb/IIIa inhibitors and long-term survival following administration during percutaneous coronary intervention for acute myocardial infarction |
| Q37585550 | Association of peripheral differential leukocyte counts with dyslipidemia risk in Chinese patients with hypertension: insight from the China Stroke Primary Prevention Trial |
| Q26782715 | Association of smoking with restenosis and major adverse cardiac events after coronary stenting: A meta-analysis |
| Q34236205 | Atherosclerosis and plaque rupture |
| Q24799248 | Atherosclerosis of the descending aorta predicts cardiovascular events: a transesophageal echocardiography study |
| Q40418236 | Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action |
| Q40872795 | Atherosclerosis: what is it and why does it occur? |
| Q73661247 | Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits |
| Q73901878 | Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery |
| Q46847348 | Atherosclerotic plaque imaging using phase-contrast X-ray computed tomography. |
| Q35027570 | B-mode ultrasound and spiral CT for the assessment of carotid atherosclerosis |
| Q74732623 | Basic and clinical aspects of myocardial stunning |
| Q58863678 | Beneficial effects of ACE-inhibition with zofenopril on plaque formation and low-density lipoprotein oxidation in watanabe heritable hyperlipidemic rabbits |
| Q89841154 | Beyond the CNS: The many peripheral roles of APOE |
| Q41368195 | Biochemical markers of myocardial damage for early diagnosis and prognosis in patients with acute coronary syndromes. Minireview based on a doctorial thesis |
| Q40563626 | Bioequivalence and tolerability study of two brands of clopidogrel tablets, using inhibition of platelet aggregation and pharmacodynamic measures |
| Q60924187 | Biología celular y molecular de las lesiones ateroscleróticas |
| Q35091945 | Blood coagulation in patients with chronic heart failure: evidence for hypercoagulable state and potential for pharmacological intervention |
| Q37221464 | Brachial artery vasoreactivity is associated with cross-sectional and longitudinal anatomical measures of atherosclerosis in postmenopausal women with coronary artery disease |
| Q44643881 | Ca2+antagonist-insensitive coronary smooth muscle contraction involves activation of ϵ-protein kinase C-dependent pathway |
| Q40874805 | Calcium-channel antagonists for prevention of atherosclerosis |
| Q73507346 | Calming the plaque to delay intervention for 24 hours in acute coronary syndromes |
| Q34557702 | Candidate genes as potential links between periodontal and cardiovascular diseases |
| Q44685657 | Cardiac parasympathetic dysfunction related to depression in older adults with acute coronary syndromes |
| Q42763375 | Cardiovascular molecular imaging as a tool to study biology |
| Q61684253 | Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS) |
| Q57364640 | Chapter 10 Caveolae and Caveolins in the Vascular System: Functional Roles in Endothelia, Macrophages, and Smooth Muscle Cells |
| Q54663237 | Characteristics of periodontal microflora in acute myocardial infarction. |
| Q33195625 | Characterization of eptifibatide during drug formulation stability assays |
| Q74088680 | Characterization of the initial alpha-thrombin interaction with glycoprotein Ib alpha in relation to platelet activation |
| Q33935019 | Chlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology |
| Q45224087 | Cholesterolemia control in Spain, 2000: a tool for cardiovascular disease prevention |
| Q50109180 | Chronic recurrent pulmonary thromboembolism in a patient with essential thrombocythemia, complicating acute right ventricular infarct |
| Q71567882 | Chronic-intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris--a pilot study |
| Q48457643 | Chronobiological patterns of onset of acute cerebrovascular diseases |
| Q80106797 | Circulating platelet and neutrophil activation correlates with the clinical course of unstable angina |
| Q40511095 | Clinical and therapeutic implications of chronic left ventricular dysfunction in coronary artery disease |
| Q50852106 | Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes. |
| Q37220360 | Clinical outcome of urgent coronary artery bypass grafting |
| Q28195760 | Clopidogrel in the Management of Ischemic Heart Disease |
| Q40440943 | Clustering of cardiovascular risk factors: Targeting high-risk individuals |
| Q46542067 | Collagen and elastin cross-linking: a mechanism of constrictive remodeling after arterial injury |
| Q33735575 | Combination therapy for acute myocardial infarction: glycoprotein IIb/IIIa inhibitors plus thrombolysis. |
| Q40230174 | Combined use of endothelial function assessed by brachial ultrasound and high-sensitive C-reactive protein in predicting cardiovascular events. |
| Q38677500 | Comparative Effectiveness of Oral Antiplatelet Agents in Patients with Acute Coronary Syndrome |
| Q92564333 | Comparison of early and delayed invasive strategies in short-medium term among patients with non-ST segment elevation acute coronary syndrome: A systematic review and meta-analysis |
| Q36294835 | Comparison of iodinated contrast media for the assessment of atherosclerotic plaque attenuation values by CT coronary angiography: observations in an ex vivo model |
| Q51549115 | Con: thoracic epidural anesthesia is not indicated in the treatment of unstable angina. |
| Q73809234 | Coronary arterial remodeling in differing clinical presentations of unstable angina pectoris--an intravascular ultrasound study |
| Q34052597 | Coronary artery disease and human immunodeficiency virus infection |
| Q35663446 | Coronary artery ectasia in Egyptian patients with coronary artery disease |
| Q26866204 | Coronary atherosclerosis is already ongoing in pre-diabetic status: Insight from intravascular imaging modalities |
| Q33802871 | Coronary microembolization--its role in acute coronary syndromes and interventions |
| Q35792398 | Coronary plaque quantification by voxel analysis: dual-source MDCT angiography versus intravascular sonography |
| Q34407436 | Coronary thrombosis |
| Q33531491 | Curcumin inhibits GPVI-mediated platelet activation by interfering with the kinase activity of Syk and the subsequent activation of PLCgamma2. |
| Q36264216 | Current perspectives on laboratory markers for the assessment of cardiovascular disease and myocardial damage |
| Q56944923 | Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: Experience from GUSTO-IIb |
| Q36009417 | Decreased Bone Mineral Density Is an Independent Predictor for the Development of Atherosclerosis: A Systematic Review and Meta-Analysis |
| Q48855551 | Decreased circulating endothelial progenitor cell levels and function in essential hypertensive patients with electrocardiographic left ventricular hypertrophy |
| Q34168401 | Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease |
| Q34262161 | Definition, classification, and pathophysiology of acute coronary ischemic syndromes |
| Q57606113 | Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction |
| Q33503491 | Dental plaque, platelets, and cardiovascular diseases |
| Q35189643 | Depression and cardiovascular disease: mechanisms of interaction |
| Q73932678 | Depression and coronary heart disease: observations and questions |
| Q33958344 | Depression in patients with cardiac disease: a practical review |
| Q44205527 | Determinants of platelet aggregation in 50-70-year-old men from three Japanese communities. |
| Q43175100 | Development of an improved assay system for activated platelet counts and evaluation by aspirin monitoring |
| Q33781183 | Diagnosis and management of patients with unstable angina |
| Q73087159 | Dietary supplementation with fermented soybeans suppresses intimal thickening |
| Q40691005 | Different isoforms of tocopherols enhance nitric oxide synthase phosphorylation and inhibit human platelet aggregation and lipid peroxidation: implications in therapy with vitamin E. |
| Q73081865 | Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis |
| Q77535798 | Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin |
| Q74556199 | Disposition of 14C-eptifibatide after intravenous administration to healthy men |
| Q37377651 | Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions |
| Q41609653 | Distinct structural attributes regulating von Willebrand factor A1 domain interaction with platelet glycoprotein Ibalpha under flow |
| Q30494371 | Distribution of ultrasonic radiofrequency signal amplitude detects lipids in atherosclerotic plaque of coronary arteries: an ex-vivo study |
| Q35579968 | Early experience with a helical coronary thrombectomy device in patients with acute coronary thrombosis |
| Q71977974 | Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage |
| Q54284502 | Effect of amlodipine on exercise-induced platelet activation in patients affected by chronic stable angina. |
| Q58106726 | Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells |
| Q44549782 | Effect of coronary artery size on the prevalence of atherosclerosis |
| Q77644026 | Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina |
| Q28196550 | Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction |
| Q40468115 | Effects of Antihypertensive Agents on Local Arterial Distensibility and Compliance |
| Q46428624 | Effects of calcium channel blockers on hyaluronidase-induced capillary vascular permeability |
| Q52527911 | Effects of coronary angioplasty on monocyte tissue factor response in patients with stable or unstable angina. |
| Q34348622 | Effects of kiwi fruit consumption on platelet aggregation and plasma lipids in healthy human volunteers |
| Q34990662 | Effects of lipids on thrombotic mechanisms in atherosclerosis |
| Q43890114 | Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST). |
| Q28194199 | Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction |
| Q37995534 | Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke |
| Q73362272 | Electron beam tomography: current practice and implications for nuclear cardiology |
| Q47191110 | Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease |
| Q40421153 | Elucidation of the role of plaque instability and rupture in acute coronary events |
| Q43504578 | Emergency coronary angioplasty following treatment with 5-fluorouracil |
| Q33367019 | Emerging anticoagulant and thrombolytic drugs |
| Q37316651 | Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries |
| Q73137299 | Endogenous nitric oxide release modulates mural platelet thrombosis and neutrophil-endothelium interactions under low and high shear conditions |
| Q35369740 | Endothelial dysfunction after non-cardiac surgery: a systematic review |
| Q41635553 | Endothelial dysfunction and atherothrombotic occlusive disease. |
| Q40861583 | Endothelial dysfunction: implications for therapy of cardiovascular diseases |
| Q58230359 | Episodic activation off the coagulation system in unstable angina does not elicit an acute phase reaction |
| Q59356310 | Establishing a New Target Range for Unfractionated Heparin for Acute Coronary Syndromes |
| Q90096050 | Evaluation of coronary artery disease in patients with atrial fibrillation by cardiac computed tomography for catheter ablation: CADAF-CT trial |
| Q47658125 | Evaluation of ion release, cytotoxicity, and platelet adhesion of electrochemical anodized 316 L stainless steel cardiovascular stents. |
| Q51775998 | Evaluation of the value of rapid D-dimer test in conjunction with cardiac troponin I test for early risk stratification of myocardial infarction. |
| Q56945278 | Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study |
| Q42827084 | Evidence for a protein S receptor(s) on human vascular smooth muscle cells. Analysis of the binding characteristics and mitogenic properties of protein S on human vascular smooth muscle cells |
| Q34562507 | Evidence for the role of Epstein Barr Virus infections in the pathogenesis of acute coronary events |
| Q38119278 | Evolution of intravascular assessment of coronary anatomy and physiology: from ultrasound imaging to optical and flow assessment |
| Q35847531 | Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis |
| Q34982919 | Exposure to smoking cues: cardiovascular and autonomic effects |
| Q52520071 | External stenting reduces early medial and neointimal thickening in a pig model of arteriovenous bypass grafting. |
| Q36078435 | Factor XIa and Thrombin Generation Are Elevated in Patients with Acute Coronary Syndrome and Predict Recurrent Cardiovascular Events |
| Q44346421 | Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates. |
| Q40492595 | Fibrinogen in Human Atherosclerosis |
| Q51287668 | Flow recirculation zone length and shear rate are differentially affected by stenosis severity in human coronary arteries. |
| Q71606960 | Focal myocardial ischemic necroses associated with unstable angina pectoris |
| Q40562735 | Functional characterization of tissue factor in von Willebrand factor-dependent thrombus formation under whole blood flow conditions. |
| Q34529610 | Functional property of von Willebrand factor under flowing blood |
| Q42194347 | GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow |
| Q40464187 | Gene therapy for the vulnerable plaque |
| Q35190833 | Genetic testing for early detection of individuals at risk of coronary heart disease and monitoring response to therapy: challenges and promises |
| Q36094351 | Genetics of platelet glycoprotein receptors: risk of thrombotic events and pharmacogenetic implications |
| Q34205595 | Glycine reduces platelet aggregation |
| Q34180931 | Glycoprotein IIb/IIIa Inhibition as an adjunct to rescue angioplasty after failed fibrinolysis |
| Q35088072 | Glycoprotein IIb/IIIa inhibition in early intent-to-stent treatment of acute coronary syndromes: EPISTENT, ADMIRAL, CADILLAC, and TARGET. |
| Q44503897 | Glycoprotein Ib-mediated platelet activation. A signalling pathway triggered by thrombin. |
| Q89934501 | Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide |
| Q42554965 | Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients |
| Q35062506 | High levels of LDL-C combined with low levels of HDL-C further increase platelet activation in hypercholesterolemic patients |
| Q40760684 | High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. |
| Q37596834 | Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques |
| Q38306676 | Historical perspective on ADP-induced platelet activation |
| Q72267698 | Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate |
| Q43745105 | Homocysteine plasma levels in young patients with coronary artery disease. Relation to history of acute myocardial infarction and anatomical extent of disease |
| Q34211191 | Hostility and platelet reactivity in individuals without a history of cardiovascular disease events |
| Q33715543 | How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions? |
| Q44632839 | Hypothalamic digoxin, hemispheric chemical dominance and syndrome X with multiple lacunar state. A hypothesis |
| Q42477528 | Identification of anti-endothelial cell antibodies in patients with chronic anal fissure |
| Q47687246 | Identification of fibrillins as a major component of coronary atherosclerotic plaques. |
| Q35854008 | Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations. |
| Q44164674 | Identification of the active region responsible for the anti-thrombotic activity of anopheline anti-platelet protein from a malaria vector mosquito |
| Q35696276 | Identification of vulnerable atherosclerotic plaques |
| Q99371201 | Identifying the RNA signatures of coronary artery disease from combined lncRNA and mRNA expression profiles |
| Q36892171 | Imaging techniques for the vulnerable coronary plaque. |
| Q53705812 | Impact of Tissue Factor Localization on Blood Clot Structure and Resistance under Venous Shear. |
| Q82662883 | Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre German Drug-Eluting Stent Registry (DES.DE) |
| Q37197102 | Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease |
| Q34180071 | Impaired modulation of circadian rhythms in patients with diabetes mellitus: a risk factor for cardiac thrombotic events? |
| Q28353718 | In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model |
| Q36930825 | In vivo optical coherence tomography of experimental thrombosis in a rabbit carotid model |
| Q71244132 | Increased plasma levels of B-type natriuretic peptide in patients with unstable angina |
| Q36833376 | Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease |
| Q77853669 | Increased winter mortality from acute myocardial infarction and stroke: the effect of age |
| Q38289775 | Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. |
| Q35880758 | Influence of convolution filtering on coronary plaque attenuation values: observations in an ex vivo model of multislice computed tomography coronary angiography |
| Q45306468 | Influence of intracoronary attenuation on coronary plaque measurements using multislice computed tomography: observations in an ex vivo model of coronary computed tomography angiography |
| Q92187535 | Inhibition of Pro-Inflammatory Cytokine Secretion by Select Antioxidants in Human Coronary Artery Endothelial Cells |
| Q73854562 | Inhibition of platelet deposition with local delivery of heparin using a double balloon catheter |
| Q35544852 | Inhibition of thrombosis and intimal thickening by in situ photopolymerization of thin hydrogel barriers |
| Q72564447 | Inhibitory effect of nitroglycerin and sodium nitroprusside on platelet activation across the coronary circulation in stable angina pectoris |
| Q24317407 | Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor |
| Q72172539 | Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty |
| Q36891131 | Integrative Multi-omic Analysis of Human Platelet eQTLs Reveals Alternative Start Site in Mitofusin 2. |
| Q44913553 | Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction |
| Q36985916 | Intracranial atherosclerotic disease; current options for surgical or medical treatment |
| Q44088088 | Intravascular radiation accelerates atherosclerotic lesion formation of hypercholesteremic rabbits |
| Q73456991 | Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin |
| Q84890804 | Intravascular ultrasound assessment of the association between spatial orientation of ruptured coronary plaques and remodeling morphology of culprit plaques in ST-elevation acute myocardial infarction |
| Q38336524 | Lack of association between platelet glycoprotein IIb/IIIa receptor PlA polymorphism and coronary artery disease or carotid intima-media thickness |
| Q28364491 | Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity |
| Q73293531 | Leptin-dependent platelet aggregation in healthy, overweight and obese subjects |
| Q43865322 | Lipid peroxidation during acute coronary syndromes and its intensification at the time of myocardial ischemia reperfusion |
| Q71774515 | Lipid-lowering interventions in angiographic trials |
| Q57419873 | Lipid-rich carotid artery plaques appear echolucent on ultrasound B-mode images and may be associated with intraplaque haemorrhage |
| Q37606038 | Lipoproteins, platelets and atherothrombosis |
| Q64382923 | Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury |
| Q93017682 | Long Noncoding Competing Endogenous RNA Networks in Age-Associated Cardiovascular Diseases |
| Q77579135 | Long-term (10-year) outcome in patients with unstable angina pectoris treated by coronary balloon angioplasty |
| Q36376147 | Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice |
| Q44292403 | Long-term prognostic value of troponin I in patients admitted to a coronary unit for unstable angina |
| Q84948895 | Low bone mineral density is not associated with angiographically determined coronary atherosclerosis in men |
| Q32063003 | Low-density lipoprotein (LDL) binds to a G-protein coupled receptor in human platelets. Evidence that the proaggregatory effect induced by LDL is modulated by down-regulation of binding sites and desensitization of its mediated signaling |
| Q72248257 | Lowering blood lipids to treat atherosclerosis: vascular tone, plaques, events, and mortality |
| Q34463849 | M-RIP targets myosin phosphatase to stress fibers to regulate myosin light chain phosphorylation in vascular smooth muscle cells |
| Q33531262 | MR plaque imaging of the carotid artery |
| Q35739811 | Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque |
| Q33671970 | Management of high-risk subsets in unstable angina |
| Q35582637 | Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes |
| Q37427120 | Mauritia flexuosa Presents In Vitro and In Vivo Antiplatelet and Antithrombotic Activities. |
| Q37257153 | Mean platelet volume reproducibility and association with platelet activity and anti-platelet therapy. |
| Q30542465 | Mechanism of lumen enlargement with direct stenting versus predilatation stenting: influence of remodelling and plaque characteristics assessed by volumetric intracoronary ultrasound |
| Q41924279 | Mechanisms for regulating platelet high density lipoprotein type3 binding sites: evidence that binding sites are downregulated by a protein kinase C-dependent mechanism |
| Q34436532 | Mechanisms of atherosclerotic plaque stabilization for a lipophilic calcium antagonist amlodipine |
| Q34371511 | Mechanisms of plaque stabilization for a charged calcium channel blocker in coronary artery disease |
| Q34989438 | Mechanisms of plaque stabilization for the dihydropyridine calcium channel blocker amlodipine: review of the evidence |
| Q33789111 | Medical treatment of the aorta. II. |
| Q45099760 | Metabolic alterations in HIV-associated lipodystrophy syndrome |
| Q33216801 | Mineral volume and morphology in carotid plaque specimens using high-resolution MRI and CT. |
| Q47761313 | Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence |
| Q34022332 | Molecular insights and therapeutic targets for diabetic endothelial dysfunction |
| Q57027216 | Morphological characteristics of optical coherence tomography defined plaque fissure in patients with acute coronary syndrome |
| Q83208267 | Multicontrast-weighted magnetic resonance imaging of atherosclerotic plaques at 3.0 and 1.5 Tesla: ex-vivo comparison with histopathologic correlation |
| Q73648032 | Multidetector-row CT of the heart |
| Q35252659 | Myocardial infarction in major noncardiac surgery: Epidemiology, pathophysiology and prevention |
| Q73808064 | Myocardial ischemia correlates with reduced fibrinolytic activity following peripheral vascular surgery |
| Q34264656 | Myosin phosphatase-Rho interacting protein. A new member of the myosin phosphatase complex that directly binds RhoA. |
| Q33901597 | N-3 fatty acids from fish and coronary artery disease: implications for public health. |
| Q28214002 | Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis |
| Q48600269 | Natriuretic peptide system gene expression in human coronary arteries |
| Q60924102 | Neovascularización en arterias coronarias humanas con distintos grados de lesión |
| Q55215331 | Neutrophil Count as a Predictor of Critical Coronary Artery Stenosis in Young Patients. |
| Q41720782 | New Antithrombotic Drugs of Coronary Artery Disease |
| Q26765488 | New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor? |
| Q47338881 | New Therapeutic Opportunities for Heparins: What Does Low Molecular Weight Heparin Offer? |
| Q37138669 | New and emerging risk factors for CVD. |
| Q77183613 | New anticoagulant drugs |
| Q41593809 | New frontiers in the management of unstable coronary artery disease |
| Q33838920 | Newer antithrombotic strategies in the initial management of non-ST-segment elevation acute coronary syndromes |
| Q40602830 | Nitrates for unstable angina |
| Q35172896 | Non-invasive detection of vulnerable coronary plaque |
| Q44524789 | Non-lipid effects of statins: myth or fact? |
| Q35551180 | Noncholesterol-Lowering Effects of Statins |
| Q41593820 | Noninvasive risk stratification in unstable coronary artery disease: exercise test and biochemical markers. FRISC Study Group |
| Q73295821 | Novel Antithrombotic Strategies for the Treatment of Coronary Artery Thrombosis: A Critical Appraisal |
| Q40716742 | Old concepts and new developments in the study of platelet aggregation |
| Q41960983 | Optimizing the imaging protocol for ex vivo coronary artery wall using high-resolution MRI: an experimental study on porcine and human |
| Q34315317 | Oral health status of patients with acute coronary syndrome--a case control study |
| Q81405232 | Overcommitment predicts restenosis after coronary angioplasty in cardiac patients |
| Q72088843 | PADGEM/GMP‐140 expression on platelet membranes from homozygous beta thalassaemic patients |
| Q34560212 | PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation |
| Q43134225 | PET/CT imaging of atherosclerotic blood vessel alterations |
| Q33987096 | PGE2 decreases reactivity of human platelets by activating EP2 and EP4 |
| Q35088060 | Pathogenetic concepts of acute coronary syndromes |
| Q64938119 | Pathology of Endovascular Stents. |
| Q41738328 | Pathophysiologic bases for adjunctive therapies in the treatment and secondary prevention of acute myocardial infarction. |
| Q34001532 | Pathophysiology and therapeutic modification of thrombin generation in patients with coronary artery disease |
| Q71129084 | Pathophysiology of coronary artery disease |
| Q73599546 | Patient-specific dosing of IIb/IIIa antagonists during acute coronary syndromes: rationale and design of the PARAGON B study. The PARAGON B International Steering Committee |
| Q38107887 | Patients who require non-cardiac surgery in acute coronary syndrome |
| Q77495353 | Percutaneous transluminal therapeutic ultrasound for high-risk thrombus-containing lesions in native coronary arteries |
| Q36908384 | Periodontal disease as a risk factor for acute myocardial infarction. A case-control study in Goans highlighting a review of the literature |
| Q40036082 | Periodontitis as a risk factor for cardiovascular disease: the role of anti-phosphorylcholine and anti-cardiolipin antibodies |
| Q47554139 | Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine |
| Q28367792 | Pharmacological profile of the novel P2T‐purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo |
| Q40636556 | Plasma concentrations of fibrinolytic factors in the subacute phase of myocardial infarction predict recurrent myocardial infarction or sudden cardiac death |
| Q35566753 | Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aortic valve disease: evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction |
| Q80587956 | Platelet GPIbalpha, GPIV and vWF polymorphisms and fatal pre-hospital MI among middle-aged men |
| Q33704606 | Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics |
| Q33951293 | Platelet adhesion receptors: novel targets for anti-thrombotic therapy |
| Q52020185 | Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris. |
| Q57259863 | Platelet collagen receptor GPIa (C807T/HPA-5) haplotype is not associated with an increased risk of fatal coronary events in middle-aged men |
| Q51892930 | Platelet deposition in non-parallel flow: influence of shear stress and changes in surface reactivity. |
| Q34135644 | Platelet function and coronary artery disease |
| Q34180960 | Platelet glycoprotein IIb/IIIa inhibitors combined with fibrinolytic agents to treat acute myocardial infarction |
| Q24793321 | Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease |
| Q33887755 | Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. |
| Q58173541 | Platelet glycoprotein IIb/IIIa receptor inhibition in primary angioplasty for acute myocardial infarction: The new paradigm of direct revascularization |
| Q73815965 | Platelet glycoprotein Ia gene dimorphism alpha2-807 in malignant arrhythmia in coronary artery disease |
| Q30483148 | Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. |
| Q35579620 | Platelet membrane glycoprotein Ibalpha gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis |
| Q33635802 | Platelet-dependent and procoagulant mechanisms in arterial thrombosis. |
| Q43844783 | Platelet-dependent thrombin generation in patients with unstable angina pectoris |
| Q35027103 | Platelets, neutrophils, and vasoconstriction after arterial injury by angioplasty in pigs: effects of MK-886, a leukotriene biosynthesis inhibitor |
| Q57607768 | Polymorphisms in the thrombopoietin gene are associated with risk of myocardial infarction at a young age |
| Q37154822 | Potential therapeutic role of statins in neurological disorders. |
| Q77291934 | Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile |
| Q34097321 | Predicting plaque rupture: enhancing diagnosis and clinical decision-making in coronary artery disease |
| Q36593847 | Predictors of Peak Troponin Level in Acute Coronary Syndromes: Prior Aspirin Use and SYNTAX Score |
| Q72230719 | Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials |
| Q35365634 | Pregnancy Associated Plasma Protein-A (PAPP-A) Levels in Acute Coronary Syndrome: A Case Control Study in a Tertiary Care Centre |
| Q37879977 | Present status of HMG reductase inhibitors in treatment of dyslipidemia |
| Q34003407 | Preventing, stopping, or reversing coronary artery disease--triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: the need for recognition and treatment |
| Q72254127 | Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits |
| Q77612978 | Procedural results and long-term clinical outcomes following coronary stenting in perimyocardial infarction syndromes |
| Q28193778 | Prognostic factors in unstable angina with dynamic electrocardiographic changes. Value of fibrinogen |
| Q70828711 | Proteolytic susceptibility of platelet low density lipoprotein receptor |
| Q77356880 | Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis |
| Q51036128 | Psychosocial characteristics and recurrent events after percutaneous transluminal coronary angioplasty. |
| Q44745252 | Questioning a class effect: does ACE inhibitor tissue penetration influence the degree of fibrinolytic balance alteration following an acute myocardial infarction? |
| Q36124892 | ROCKs as therapeutic targets in cardiovascular diseases |
| Q44175110 | Radical trapping in glycogen storage disease 1a. |
| Q37828216 | Radionuclide imaging of the synthetic smooth muscle cell phenotype in experimental atherosclerotic lesions |
| Q42021106 | Raised interleukin 6 concentrations as a predictor of postangioplasty restenosis |
| Q47229682 | Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events |
| Q48974343 | Rationale and design of the EPISTEME trial: efficacy of post-stroke intensive rosuvastatin treatment for aortogenic embolic stroke |
| Q41593838 | Reactivation of the coagulation system: rationale for long-term antithrombotic treatment |
| Q74587116 | Reactivity of human platelets with immobilized fibrinogen is dictated by the chemical character of the surface |
| Q40829771 | Recent antiplatelet drug trials in the acute coronary syndromes. Clinical interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT. |
| Q47331075 | Reduction of reinfarction and angina with use of low-molecular-weight heparin therapy after streptokinase (and heparin) in acute myocardial infarction |
| Q36888651 | Refractory angina pectoris in end-stage coronary artery disease: evolving therapeutic concepts. |
| Q33607199 | Regression of atherosclerosis--an ounce of prevention. |
| Q40935662 | Relation between perfusion defects on stress technetium-99m sestamibi SPECT scintigraphy and the location of a subsequent acute myocardial infarction |
| Q44088732 | Relation of plasma homocysteine levels to intracoronary thrombus in unstable angina pectoris and in non-Q-wave acute myocardial infarction |
| Q79262032 | Relationship between metabolic syndrome and platelet responsiveness to leptin in overweight and obese patients |
| Q37175334 | Relationship between retinal vascular caliber and coronary artery disease in patients with non-alcoholic fatty liver disease (NAFLD) |
| Q40636563 | Release of cardiac troponin I after temporally graded acute coronary ischaemia with electrocardiographic ST depression |
| Q37207656 | Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2 |
| Q38665263 | Reperfusion strategies in acute myocardial infarction and multivessel disease |
| Q41077495 | Restenosis: pathophysiology and preventive strategies |
| Q39446390 | Restoration of coronary blood flow by single bolus injection of the GPIIb/IIIa receptor antagonist c7E3 Fab in a patient with acute myocardial infarction of recent onset. |
| Q73370400 | Results of coronary stenting for unstable versus stable angina pectoris |
| Q73052486 | Retrobulbar and peripheral capillary blood flow in hypercholesterolemic subjects |
| Q62760842 | Rheologische Determinanten von Endorgansch�den |
| Q52355127 | Risk Stratification and in Hospital Morality in Patients Presenting with Acute Coronary Syndrome (ACS) in Bahrain. |
| Q42578006 | Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content |
| Q34445660 | Risk stratification in non-ST segment elevation acute coronary syndromes with special focus on recent guidelines. |
| Q34247699 | Risk stratification in patients with chest pain |
| Q35557406 | Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes |
| Q37683958 | Role of acute infection in triggering acute coronary syndromes. |
| Q35166649 | Role of fibrin D-dimer testing in emergency medicine. |
| Q41593796 | Role of inflammation in the pathogenesis of unstable coronary artery disease. |
| Q54325092 | S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling. |
| Q92572609 | ST-segment elevation myocardial infarction |
| Q35372354 | Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound |
| Q51702439 | Scrub typhus increases the risk of developing acute coronary syndrome: a nationwide cohort study. |
| Q52237608 | Secondary prevention of coronary heart disease. |
| Q57189831 | Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo |
| Q40771622 | Sex differences in coronary artery size assessed by intravascular ultrasound |
| Q36982633 | Sex differences in hospital mortality following acute myocardial infarction in China: findings from a study of 45 852 patients in the COMMIT/CCS-2 study |
| Q48589128 | Sex-related dimorphic response of HIF-1 alpha expression in myocardial ischemia |
| Q74050918 | Shear-induced platelet aggregation increases in patients with proximal and severe coronary artery stenosis |
| Q35100297 | Statin treatment and progression of atherosclerotic plaque burden |
| Q33181373 | Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins |
| Q33876942 | Statins: effective antiatherosclerotic therapy |
| Q47595334 | Symptomatic vs. asymptomatic plaque classification in carotid ultrasound |
| Q56897486 | Targeted delivery of thrombolytic agents: role of integrin receptors |
| Q35760257 | Testosterone Replacement Therapy Prevents Alterations of Coronary Vascular Reactivity Caused by Hormone Deficiency Induced by Castration. |
| Q73091569 | The GPIIIa Pl(A) polymorphism in the progression of abdominal aortic atherosclerosis |
| Q35584004 | The Role of Glycoprotein IIb/IIIa-Receptor Antagonists in Diabetics |
| Q46011354 | The VYtorin on Carotid intima-media thickness and overall arterial rigidity (VYCTOR) study. |
| Q33718529 | The crystal structure of the active domain of Anopheles anti-platelet protein, a powerful anti-coagulant, in complex with an antibody |
| Q35114692 | The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIb |
| Q28188566 | The effect of human platelet alloantigen polymorphisms on the in vitro responsiveness to adrenaline and collagen |
| Q38678569 | The emerging role of interleukin-37 in cardiovascular diseases |
| Q37037463 | The evaluation of cardiac and peripheral arterial disease in patients with diabetes mellitus |
| Q35088077 | The evolving role of direct thrombin inhibitors in acute coronary syndromes |
| Q33818141 | The evolving role of statins in the management of atherosclerosis |
| Q33671901 | The health care burden of unstable angina |
| Q30500012 | The impact of carotid plaque presence and morphology on mortality outcome in cardiological patients |
| Q71728230 | The inflammatory etiology of unstable angina |
| Q40421170 | The influence of pretreatment low density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials. Harvard Atherosclerosis Reversibility Project Research Group |
| Q37947959 | The management of thrombotic lesions in the cardiac catheterization laboratory |
| Q34421664 | The mechanisms of thrombotic risk induced by hormone replacement therapy |
| Q33641457 | The platelet in acute coronary syndromes: defining the pivotal role of platelet glycoprotein IIb/IIIa receptor blockade |
| Q48578051 | The progression of thrombus in an ex-vivo shunt model evaluated by intravascular ultrasound radiofrequency analysis |
| Q53236487 | The relationship between serum levels of Zn and Cu and severity of coronary atherosclerosis. |
| Q33835675 | The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis |
| Q34531472 | The reperfusion era. Strategies for establishing or maintaining coronary patency |
| Q48005312 | The response of smooth muscle cells to alpha-thrombin depends on its arterial origin: comparison among different species |
| Q36059492 | The role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in modern rheumatology |
| Q84773086 | The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes |
| Q33568558 | The role of angioplasty in acute myocardial infarction |
| Q44630310 | The role of myocardial revascularization preceding noncardiac surgery |
| Q33870602 | The role of plaque rupture and thrombosis in coronary artery disease |
| Q28195431 | The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction |
| Q58136303 | The use of echocardiography for the non-invasive evaluation of coronary artery disease |
| Q33904627 | The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends |
| Q40779843 | The vascular endothelium. A new horizon |
| Q35035390 | The vulnerable plaque and acute coronary syndromes |
| Q70478093 | Thrombolytic agents in critical care |
| Q74815558 | Thrombolytic therapy: a review of its use in acute myocardial infarction |
| Q33671919 | Thrombosis and coagulation abnormalities in the acute coronary syndromes |
| Q40938710 | Thrombosis and the pharmacology of antithrombotic agents |
| Q38243253 | Thrombosis formation on atherosclerotic lesions and plaque rupture |
| Q33504832 | Tirofiban. A review of its use in acute coronary syndromes |
| Q33838184 | Tissue factor in human coronary atherosclerotic plaques |
| Q73164621 | Tissue-factor antigen and activity in human coronary atherosclerotic plaques |
| Q43643204 | Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group |
| Q74530775 | Troponin T: a sensitive and specific diagnostic and prognostic marker of myocardial damage |
| Q46876090 | Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment |
| Q40421159 | Unresolved issues in early trials of cholesterol lowering |
| Q33635822 | Unstable angina and non Q-wave myocardial infarction. Early risk stratification: role of silent ischemia and coronary morphology |
| Q38547536 | Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications? |
| Q40925433 | Unstable angina: new insights into pathophysiologic characteristics, prognosis, and management strategies |
| Q40657398 | Unstable angina: prognosis, noninvasive risk assessment, and strategies for management |
| Q41519607 | Use of cardiac markers as assessed by outcomes analysis |
| Q34300585 | Use of statins in CNS disorders |
| Q35764395 | Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. |
| Q37902114 | Vascular targeting of antithrombotic agents |
| Q82326786 | Vein thromboembolism prevention in stroke patients |
| Q41155350 | Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease |
| Q36138848 | Visualising noncalcified coronary plaques by CT. |
| Q73503945 | Vitamin C prevents the acute atherogenic effects of passive smoking |
| Q74084731 | [Conservative therapeutic approaches in terminal coronary heart disease. Chronic intermittent urokinase therapy] |
| Q74178835 | [Control of cholesterolemia in Spain, 2000. A tool for cardiovascular prevention] |
| Q81057408 | [Differential circadian rhythms in myocardial infarction according to its extent by electrocardiogram] |
| Q73298197 | [Endothelial dysfunction in patients with acute coronary syndrome] |
| Q73540801 | [Genetic risk factors for myocardial infarct] |
| Q80106732 | [Inflammation in acute coronary syndromes: mechanisms and clinical implications] |
| Q53868946 | [Interleukin-10 and coronary disease]. |
| Q73713101 | [Rationale for lipid therapy. Prevention or treatment of coronary heart disease?] |
| Q77782856 | [Successful emergency coronary artery bypass grafting after use of a percutaneous cardiopulmonary support system in a patient with cardiopulmonary arrest secondary to acute myocardial infarction] |
| Q73538114 | [The efficacy of platelet IIb/IIIa receptor blockers in acute coronary syndromes] |
| Q80994036 | [Von Willebrand factor, endothelial lesion, and ischemic heart disease] |
| Q33654586 | d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties |
| Q73101411 | von Willebrand factor |
Search more.